***Background.*** Spontaneous bacterial peritonitis (SBP) is associated with poor clinical outcomes. Empiric treatment of SBP with a third-generation cephalosporin (3^rd^-ceph) is standard of care. Studies show increasing rates of 3^rd^-ceph resistance, but limited data is available from the United States.

***Methods.*** Cirrhotic patients diagnosed with SBP at The Mount Sinai Hospital were retrospectively identified by ICD-9 code. Clinical and demographic data were collected. Health care-associated SBP (HCA-SBP) was defined as hospitalization in the prior 90 days; hospital-acquired SBP (HA-SBP) was defined as diagnosis after 72 hours of hospitalization. Among those who underwent repeat paracentesis, initial treatment failure was defined as \<25% decrease in ascitic fluid neutrophil count on treatment day 2 or 3. Risk factors for 30-day mortality were analyzed.

***Results.*** Between January 1, 2010 and July 31, 2013, 186 patients with SBP were identified. Mean age was 59; 70% of patients were male. Average MELD score at time of SBP diagnosis was 26. Cirrhosis was due to hepatitis C in 53% of patients and alcohol in 33%. HCA-SBP was observed in 40%; HA-SBP in 30%; and community-acquired SBP (CA-SBP) in 30% of the patients.

  ------------------------------------------------------------------------------------------------------------
                                 HA-SBP                     HCA-SBP                    CA-SBP
  ------------------------------ -------------------------- -------------------------- -----------------------
  Any culture +                  17/55 (31%)                20/74 (27%)                20/57(35%)

  Ascitic fluid culture + only   8/55 (15%)                 12/20 (60%)                6/20 (30%)

  Blood culture + only           6/55 (11%)                 7/20 (35%)                 9/20 (45%)

  Both cultures +                3/55(5%)                   1/20 (5%)                  5/20 (25%)

  Gram-positive bacteria         10/17 (59%)                13/20 (65%)                10/20 (50%)

  Most frequent bacteria         *E. coli*(4, 2 ESBL)\      *E. coli*(3, 2 ESBL)\      *E. coli*(7, 2 ESBL)\
                                 *Klebsiella*(3, 1 ESBL)\   *Enterococcus*(2,1 VRE)\   *Klebsiella*(3)\
                                 VRE (3)                    MRSA (2)                   *S. pneumoniae* (2)

  Initial tx with 3^rd^-ceph     29/55 (53%)                56/74 (76%)                40/57 (70%)

  3rd-ceph resistance            7/20 (35%)                 6/21 (29%)                 3/24 (13%)

  Initial treatment failure      4/41 (15%)                 22/43 (51%)                15/38 (39%)

  30-day mortality               32/55 (58%)                16/74 (22%)                6/57 (11%)
  ------------------------------------------------------------------------------------------------------------

Increased 30-day mortality was significantly associated with HA-SBP (OR 4.99, 95% CI 2.46-10.13) and recent (\<30 days prior to SBP diagnosis) antibiotic exposure (OR 2.35, CI 1.21-4.57). Decreased 30-day mortality was significantly associated with repeat paracentesis at day 2-3 (OR 0.33, CI 0.16-0.70).

***Conclusion.*** HA-SBP and recent antibiotic exposure were significantly associated with early mortality. 3^rd^-ceph resistance was more common in HA-SBP and HCA-SBP.
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